Contact Us   |   Sign In   |   Donate now
Research Grants - General
Share |




The Theriogenology Foundation offers research grants up to $5,000 for proposals that focus on all aspects of Theriogenology including (infertility, endocrinology, neonatology, obstetrics, etc.). In exceptional circumstances, grants up to $10,000 may be considered. 


The following are eligible as Principal investigators for the Theriogenology Foundation research grants  

  1. Active Diplomates or Honorary Members of the ACT 
  2. Veterinarians that are SFT members in private practice, industry or on faculty. 
  3. Residents enrolled in ACT approved residency programs, including the alternate route, and have a minimum of one year remaining in their training program 
  4. A PI may submit more than one proposal however, only one proposal from that PI will be funded in a given year.

Pre-proposal must be submitted prior to February 15, 11:59PM EST
Submit by email to

Click here for pre-proposal guidelines

Pre-proposals selected by the Research committee for full submission must adhere to the following guidelines:

Preparation of the proposal:

Proposals should be prepared in word or compatible format as follows

  • Page size: 8.5" x 11" with margins set at 0.75" on all sides.
  • Pages should be numbered consecutively with the page number appearing in the bottom center of each page. The cover page is counted as page 1, but the cover page should not be numbered. Begin page numbering with the abstract page (page 2), which immediately follows the cover page.
  • Text should be single-spaced in font 12 point Times New Roman. 


1.  Complete proposal package should be submitted in PDF format to and include:

  • Signed and dated cover sheet
  • Checklist page, and other documents
  • Information on, should the research grant be awarded, to whom the check should be made payable to, including complete address
  • Completed W9 form

2. Deadline for submission is 11:59PM EST April 15.

Submissions received after this date will not be considered 


The Principal Investigator will be notified by email of the receipt of the proposal within three weeks. 

  • The Principal Investigator will be notified by email of the result of review of the proposal by June 30. 
  • The written review of the proposal will follow the e-mail result announcement.  
  • All decisions of the Research Grant Committee are final. However, re-submission of revised proposals for the next funding cycle are encouraged.

Proposal Outline: 

The proposal should be strictly organized as outlined below. Proposals that fail to adhere to these guidelines may be rejected without further consideration. Note that page limits are maximums, and it is not necessary to fill them if the needed information can be provided in less space.  

Title Page (See Appendix 1)  

Proposal Title - Limit title to 75 characters, including spaces.  

Principal Investigator - List name, degree(s), and position 

Contact information - Mailing address, e-mail, and telephone and FAX numbers for Principal Investigator. 

Co-Principal Investigator - List name, degree(s), and position 

Co-investigator(s) - List name, degree(s) and position of each co-investigator.  

Amount requested – Annual and total amount of funds requested from this program. Maximum available funds (total costs to the Foundation) is $10,000. Proposals may request up to the total amount and multi-year projects up to three years will be considered, subject to annual non-competitive renewal based on demonstration of adequate progress on the project.  

Signatures and date - The PI, Co-PI, collaborators, and the Institutional Representative must sign and date the proposal. Include (in PDF format) in the electronically submitted proposal package or mail separately by submission deadline.  

Institutional Representative - Contact information for the individual who is authorized to accept payment for the institution/practice. Clearly indicate how a check should be made out and the address to which a check should be mailed, in the event of an award.  

Abstracts (1 page maximum)

  • Scientific abstract – The scientific abstract should not be more that 250 words in length and should clearly state the importance of the study, hypothesis, objectives, materials and methods.
  • Lay abstract – should be 250 words or less and explain in language suitable for lay people the importance of the study and its objectives.
  • Hypothesis and specific aims (1 page maximum) - The Hypothesis and Specific Aims of the proposed project should be precisely stated. It is important to have clearly defined Specific Aims that can be achieved within the scope of the proposal. The expected time period to achieve each Specific Aim should be indicated.

            Background, Design, Methods, and Analysis (5 page maximum)

o    Background and significance - The background section should be concise and thorough. The information provided should be sufficient to allow reviewers to judge the merits of the proposed project. Information from previously published literature on the topic and relevant recent investigations should be included and referenced. The significance of the proposed research to Theriogenology should be discussed.

o    Preliminary data - Preliminary data that support the proposal, either by providing support for the overall hypothesis or by demonstrating the ability of the investigators to perform the proposed experiments, should be reported. The use of photos, tables, figures and other graphics is encouraged.

o    Study Design, Methods, Statistical and Data Analysis

  • Study design - Provide precise details about the study design. Information such as the number of study groups, the expected number of animals in each group, and details about treatment, samples to be taken, and monitoring should be included here. Studies that involve enrollment of client-owned animals should provide documentation that the caseload is sufficient to provide opportunities to enroll the expected number of animals.
    • Methods - Describe the methods that will be employed to achieve the Specific Aims of the project. Provide sufficient detail to allow reviewers to judge the feasibility of the proposed methods for achieving the stated objective.
    • Statistical and data analysis - Describe how the results of the study will be analyzed, including information about statistical methods that will be used. Sample size must be justified by the use of statistical techniques.

Provide a detailed budget for how the funds will be used. Provide a short justification for each budget item. Clearly indicate the amount of funds requested for each budget category listed and the total amount requested for the project.

Allowable costs
The TF research grants do not allow for overhead, major equipment (>$1,000) or investigators salaries. Travel cost is only allowed for the purpose of travel to the site of study for acquisition of samples. Cost of publication is not supported.

References (1 page maximum)
Provide complete reference information for all literature cited. List references in the reference format used by Clinical Theriogenology

Facilities description (1 page maximum) –
Describe the environment of each institution/practice where the project will be performed. Include specific information about the clinical and scientific equipment and facilities available to the investigators. When determining the feasibility of a proposed project, it is important for the reviewers to know whether the major equipment and facilities needed to complete the project are available to the investigators.

Supporting Documents
Letters of collaboration from consultants and collaborators should be provided unless they are listed as co-investigators, in which case signature as Co-PI is sufficient.

Institutional/other party commitments and assurances
A letter must be included from an individual who can indicate the institution’s commitment to the PI to perform the project, use of any equipment and facilities, and any matching funds. In academic institutions this will usually be from a department chair or associate dean for research. In a private clinical practice, a letter from the practice owner or hospital administrator is appropriate. For proposals that involve multiple institutions, separate letters from each institution / practice are required.

Disclosure statements
A disclosure statement is required of the PI and each co-investigator listed on the cover page of the proposal and should specifically include: disclosure of any business or financial interests the investigator has in the proposed project or its results; a statement about whether the proposed investigation(s) is intended to produce results that will form, wholly or in part, the basis for a patent application; the existence of any agreements or contracts that may interfere or prohibit the distribution, publication, and reporting of the study results; and any other information that could impact the timely facilitation and completion of the proposed studies.

Biographical sketches – (please see Appendix 3)
A short biographical sketch is required for the PI, Co-PI and collaborators who contribute significantly toward the generation of data. Each biographical sketch should be limited to two pages.

Institutional Animal Care and Use Committee (IACUC) and Institutional Biosafety approvals
Studies involving laboratory animals must be approved by the Institutional Animal Care and Use Committee (IACUC) of the institution where the work is to be done. Documentation of approval by the IACUC must be provided in the event funding is awarded. Since funding will not be released until approved animal care forms are received by the Foundation, it is strongly advised that IACUC and Biosafety panel approvals be submitted with the proposal, as this will expedite release of grant funds.

Projects that involve the use of recombinant DNA, viral vectors, and / or radioactivity must be approved by the Institutional Biosafety Office of the institution where the work is to be done. A copy of the Institutional Biosafety Office approval must be provided in the event funding is awarded. If the proposed project does not require IACUC or Institutional Biosafety approval, please include a statement that indicates that the proposed project is exempt and explains why.

Funds will not be released until the Foundation receives proof that final institutional approval for the project has been obtained.
In private practice situations, an informed consent form must be signed by every owner of a patient enrolled in the study. A copy of the informed consent form should be included with the proposal. 

Previous Theriogenology Foundation funding
Indicate whether the PI has received previous funding from The Theriogenology Foundation. List the project title and dates of previous funding and any publications that directly resulted from the project.

Publication of results
The investigators are required to recognize the funding support of the Theriogenology Foundation in all publications that result from the project. A copy of the published manuscript should be submitted to the TF.

Results of funded studies should be reported to the Theriogenology Foundation within six months of completion. In multi-year studies, an annual progress report is expected. (Due November 1st)

Appendix 1 - Title page

Appendix 2 - Biographical Sketch

Grant Proposal Checklist

Community Search